Evidence map›Paper›PMID 36417349›Full record

ArticlePloS one2022

Cannabis use in pregnancy and maternal and infant outcomes: A Canadian cross-jurisdictional population-based cohort study.

Sabrina Luke, Amy J Hobbs, Michaela Smith, Catherine Riddell, Phil Murphy, Calypse Agborsangaya, Christina Cantin, John Fahey, Kenny Der, Ann Pederson and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Cannabis use, preterm birth, and small for gestational age: findings from the national birth defects prevention study.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Evidence on the effect of in-utero cannabis exposure in neonates.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Sabrina LukePerinatal Services British Columbia, Provincial Health Services Authority, Vancouver, British Columbia, Canada.ORCID 0000-0001-8394-4610
Amy J HobbsPerinatal Services British Columbia, Provincial Health Services Authority, Vancouver, British Columbia, Canada.ORCID 0000-0003-2242-7868
Michaela SmithBetter Outcomes Registry Network Ontario, Ottawa, Ontario, Canada.
Catherine RiddellBetter Outcomes Registry Network Ontario, Ottawa, Ontario, Canada.
Phil MurphyChildren's & Women's Health Program, Eastern Health, St. John's, Newfoundland and Labrador, Canada.
Calypse AgborsangayaAlberta Health, Edmonton, Alberta, Canada.
Christina CantinChamplain Maternal Newborn Regional Program, Ottawa, Ontario, Canada.ORCID 0000-0002-1535-5520
John FaheyReproductive Care Program of Nova Scotia, Halifax, Nova Scotia, Canada.
Kenny DerPerinatal Services British Columbia, Provincial Health Services Authority, Vancouver, British Columbia, Canada.
Ann PedersonPerinatal Services British Columbia, Provincial Health Services Authority, Vancouver, British Columbia, Canada.
Chantal NelsonPublic Health Agency of Canada, Ottawa, Ontario, Canada.
National Maternal Cannabis Working Group
Provincial Health Services Authority · CAOntario Stroke Network · CAAlberta Health · CACancer Care Nova Scotia · CAChamplain Regional College · CAJohns Hopkins University · USPublic Health Agency of Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the recent legalization of cannabis in Canada, there is an urgent need to understand the effect of cannabis use in pregnancy. Our population-based study investigated the effects of prenatal cannabis use on maternal and newborn outcomes, and modification by infant sex.

methodsThe cohort included 1,280,447 singleton births from the British Columbia Perinatal Data Registry, the Better Outcomes Registry & Network Ontario, and the Perinatal Program Newfoundland Labrador from April 1st, 2012 to March 31st, 2019. Logistic regression determined the associations between prenatal cannabis use and low birth weight, small-for-gestational age, large-for-gestational age, spontaneous and medically indicated preterm birth, very preterm birth, stillbirth, major congenital anomalies, caesarean section, gestational diabetes and gestational hypertension. Models were adjusted for other substance use, socio-demographic and-economic characteristics, co-morbidities. Interaction terms were included to investigate modification by infant sex.

resultsThe prevalence of cannabis use in our cohort was approximately 2%. Prenatal cannabis use is associated with increased risks of spontaneous and medically indicated preterm birth (1.80[1.68-1.93] and 1.94[1.77-2.12], respectively), very preterm birth (1.73[1.48-2.02]), low birth weight (1.90[1.79-2.03]), small-for-gestational age (1.21[1.16-1.27]) and large-for-gestational age (1.06[1.01-1.12]), any major congenital anomaly (1.71[1.49-1.97]), caesarean section (1.13[1.09-1.17]), and gestational diabetes (1.32[1.23-1.42]). No association was found for stillbirth or gestational hypertension. Only small-for-gestational age (p = 0.03) and spontaneous preterm birth (p = 0.04) showed evidence of modification by infant sex.

conclusionsPrenatal cannabis use increases the likelihood of preterm birth, low birth weight, small-for-gestational age and major congenital anomalies with prenatally exposed female infants showing evidence of increased susceptibility. Additional measures are needed to inform the public and providers of the inherent risks of cannabis exposure in pregnancy.

Indexed as

CannabisDiabetes, GestationalHallucinogensHypertension, Pregnancy-InducedPremature BirthAnalgesicsBritish ColumbiaCannabinoid Receptor AgonistsCesarean SectionCohort StudiesFemaleHumansInfantInfant, NewbornPregnancyStillbirthAnalgesicsCannabinoid Receptor AgonistsHallucinogens

Identifiers

PMID36417349
PMCPMC9683571
OpenAlexW4309797046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.